Cargando…
Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993265/ https://www.ncbi.nlm.nih.gov/pubmed/29892542 http://dx.doi.org/10.1016/j.lrr.2018.01.002 |
| _version_ | 1783330212340039680 |
|---|---|
| author | Peterlin, Pierre Guillaume, Thierry Garnier, Alice Le Bourgeois, Amandine Mahé, Beatrice Dubruille, Viviane Blin, Nicolas Gallas, Pierre Touzeau, Cyrille Gastinne, Thomas Lok, Anne Thomare, Patrick Chauvin, Cecile Le Gouill, Steven Moreau, Philippe Chevallier, Patrice |
| author_facet | Peterlin, Pierre Guillaume, Thierry Garnier, Alice Le Bourgeois, Amandine Mahé, Beatrice Dubruille, Viviane Blin, Nicolas Gallas, Pierre Touzeau, Cyrille Gastinne, Thomas Lok, Anne Thomare, Patrick Chauvin, Cecile Le Gouill, Steven Moreau, Philippe Chevallier, Patrice |
| author_sort | Peterlin, Pierre |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5993265 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59932652018-06-11 Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases Peterlin, Pierre Guillaume, Thierry Garnier, Alice Le Bourgeois, Amandine Mahé, Beatrice Dubruille, Viviane Blin, Nicolas Gallas, Pierre Touzeau, Cyrille Gastinne, Thomas Lok, Anne Thomare, Patrick Chauvin, Cecile Le Gouill, Steven Moreau, Philippe Chevallier, Patrice Leuk Res Rep Article Elsevier 2018-01-17 /pmc/articles/PMC5993265/ /pubmed/29892542 http://dx.doi.org/10.1016/j.lrr.2018.01.002 Text en © 2018 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Article Peterlin, Pierre Guillaume, Thierry Garnier, Alice Le Bourgeois, Amandine Mahé, Beatrice Dubruille, Viviane Blin, Nicolas Gallas, Pierre Touzeau, Cyrille Gastinne, Thomas Lok, Anne Thomare, Patrick Chauvin, Cecile Le Gouill, Steven Moreau, Philippe Chevallier, Patrice Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases |
| title | Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases |
| title_full | Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases |
| title_fullStr | Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases |
| title_full_unstemmed | Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases |
| title_short | Subcutaneous rituximab given to patients for other indications than CD20+ B-cell lymphoma: A monocentric study of 20 cases |
| title_sort | subcutaneous rituximab given to patients for other indications than cd20+ b-cell lymphoma: a monocentric study of 20 cases |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993265/ https://www.ncbi.nlm.nih.gov/pubmed/29892542 http://dx.doi.org/10.1016/j.lrr.2018.01.002 |
| work_keys_str_mv | AT peterlinpierre subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT guillaumethierry subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT garnieralice subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT lebourgeoisamandine subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT mahebeatrice subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT dubruilleviviane subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT blinnicolas subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT gallaspierre subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT touzeaucyrille subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT gastinnethomas subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT lokanne subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT thomarepatrick subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT chauvincecile subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT legouillsteven subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT moreauphilippe subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases AT chevallierpatrice subcutaneousrituximabgiventopatientsforotherindicationsthancd20bcelllymphomaamonocentricstudyof20cases |